GSK Oncology is committed to shaping cancer care through a diverse pipeline of innovative agents and novel combinations. We have established a focused effort in Cancer Epigenetics, Immuno-Oncology, and Oncology Cell Therapy. GSK welcomes collaborations with the oncology R&D community on our investigational agents in solid tumors and hematologic malignancies.